SEC Form 4 · accession 0001127602-15-009305
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Jonas
Officer — EVP Legal Affairs,Gen. Counsel
Period of report
Feb 27, 2015
Accepted (ET)
Mar 3, 2015 · 12:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rsus (restricted Stock Units)F1 | $0.00 | Feb 27, 2015 | A | 4,100 | A | — | Feb 27, 2025 | Common Stock | 4,100 | 4,100 | D |
| Sars (Stock Appreciation Rights)F2 | $51.30 | Feb 27, 2015 | A | 24,800 | A | — | Feb 27, 2025 | Common Stock | 24,800 | 24,800 | D |
Explanation of responses
- F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
- F2The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (20%) over a five year period.